Patient values and preferences when choosing anticoagulants
Authors:
Open Access
- 1 January 2015
- journal article
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. 9, 133-138
Abstract
Patient values and preferences when choosing anticoagulants Ana M Palacio,1–3 Irene Kirolos,2,3 Leonardo Tamariz1–3 1The Department of Medicine, Miller School of Medicine, University of Miami, 2The Veterans Affairs Medical Center, Miami, FL, USA; 3Division of Public Health Sciences, University of Miami, Miami, Florida, USA Background: New oral anticoagulants have similar efficacy and lower bleeding rates compared with warfarin. However, in case of bleeding there is no specific antidote to reverse their effects. We evaluated the preferences and values of anticoagulants of patients at risk of atrial fibrillation and those who have already made a decision regarding anticoagulation.Methods: We conducted a cross-sectional study of Veterans in the primary care clinics and the international normalized ratio (INR) laboratory. We developed an instrument with patient and physician input to measure patient values and preferences. The survey contained a hypothetical scenario of the risk of atrial fibrillation and the attributes of each anticoagulant. After the scenario, we asked participants to choose the option that best fits their preferences. The options were: 1) has better efficacy at reducing risk of stroke; 2) has been in the market for a long period of time; 3) has an antidote to reverse the rare case of bleeding; 4) has better quality of life profile with no required frequent laboratory tests; or 5) I want to follow physician recommendations. We stratified our results by those patients who are currently exposed to anticoagulants and those who are not exposed but are at risk of atrial fibrillation.Results: We approached 173 Veterans and completed 137 surveys (79% response rate). Ninety subjects were not exposed to anticoagulants, 46 reported being on warfarin, and one reported being on dabigatran at the time of the survey. Ninety-eight percent of subjects stated they would like to participate in the decision-making process of selecting an anticoagulant. Thirty-six percent of those exposed and 37% of those unexposed to anticoagulants reported that they would select a medication that has an antidote even if the risk of bleeding was very small. Twenty-three percent of the unexposed and 22% of the exposed groups reported that they would prefer the medication that gives the best quality of life.Conclusion: Our study found that patients who may be exposed to an anticoagulation decision prefer to actively participate in the decision-making process, and have individual values for making a decision that cannot be predicted or assumed by anyone in the health care system. Keywords: warfarin, oral anticoagulant, bleeding risk, atrial fibrillation, patient decision making, medication selectionKeywords
This publication has 19 references indexed in Scilit:
- New Oral Anticoagulants Are Not Superior to Warfarin in Secondary Prevention of Stroke or Transient Ischemic Attacks, but Lower the Risk of Intracranial Bleeding: Insights from a Meta-Analysis and Indirect Treatment ComparisonsPLOS ONE, 2013
- Interventions for providers to promote a patient-centred approach in clinical consultationsCochrane Database of Systematic Reviews, 2012
- Study of Warfarin Patients Investigating Attitudes Toward Therapy Change (SWITCH Survey)American Journal of Therapeutics, 2012
- Patient preferences and willingness to pay for different options of anticoagulant therapyInternal and Emergency Medicine, 2012
- Patients’ and health professionals’ views and experiences of atrial fibrillation and oral-anticoagulant therapy: A qualitative meta-synthesisPatient Education and Counseling, 2012
- Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocolBMC Pregnancy and Childbirth, 2012
- Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolismPatient Preference and Adherence, 2010
- Translating the Results of Randomized Trials into Clinical PracticeStroke, 2006
- Avoidance hierarchies and preferences for anticoagulation--semi-qualitative analysis of older patients' views about stroke prevention and the use of warfarinAge and Ageing, 2004
- Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational studyCommentary: Varied preferences reflect the reality of clinical practiceBMJ, 2001